DiaMedica Therapeutics Inc.DiaMedica Therapeutics Inc.DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc.

No trades
See on Supercharts

Price target

7.000.00 0.00%
The 3 analysts offering 1 year price forecasts for DMAC have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to DMAC in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

DMAC EPS for the last quarter is −0.12 USD despite the estimation of −0.14 USD. In the next quarter EPS is expected to reach −0.16 USD. Track more of DiaMedica Therapeutics Inc. financials and stay on top of what is up with the company.
According to analysts, DMAC price target is 7.00 USD with a max estimate of 8.00 USD and a min estimate of 6.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with DMAC news and stock market news.